EP0804542A4 - METHOD FOR THE PRODUCTION OF REINFORCED ANTI-INTELLECTORY BACTERIA AND VACCINES CONTAINED THEREFORE - Google Patents

METHOD FOR THE PRODUCTION OF REINFORCED ANTI-INTELLECTORY BACTERIA AND VACCINES CONTAINED THEREFORE

Info

Publication number: EP0804542A4
Authority: EP; European Patent Office
Prior art keywords: intellectory; bacteria; production; reinforced anti; vaccines contained
Prior art date: 1994-10-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP95937449A

Other languages

German (de)

French (fr)

Other versions

EP0804542A1 (en

Inventor

John L Pace

Richard I Walker

Steven M Frey

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Emergent Product Development Gaithersburg Inc

Original Assignee

Antex Biologics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-05

Filing date

1995-10-04

Publication date

1998-10-28

1995-10-03 Priority claimed from US08/538,543 external-priority patent/US5681736A/en

1995-10-04 Application filed by Antex Biologics Inc filed Critical Antex Biologics Inc

1997-11-05 Publication of EP0804542A1 publication Critical patent/EP0804542A1/en

1998-10-28 Publication of EP0804542A4 publication Critical patent/EP0804542A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Analytical Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP95937449A 1994-10-05 1995-10-04 METHOD FOR THE PRODUCTION OF REINFORCED ANTI-INTELLECTORY BACTERIA AND VACCINES CONTAINED THEREFORE Withdrawn EP0804542A4 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US538543		1990-06-15
US31840994A	1994-10-05	1994-10-05
US318409		1994-10-05
US08/538,543 US5681736A (en)	1994-10-05	1995-10-03	Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US08/538,545 US5679564A (en)	1994-10-05	1995-10-03	Methods for producing enhanced antigenic campylobacter bacteria and vaccines
US538545		1995-10-03
PCT/US1995/013196 WO1996011258A1 (en)	1994-10-05	1995-10-04	Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same

Publications (2)

Publication Number	Publication Date
EP0804542A1 EP0804542A1 (en)	1997-11-05
EP0804542A4 true EP0804542A4 (en)	1998-10-28

Family

ID=27405987

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP95937449A Withdrawn EP0804542A4 (en)	1994-10-05	1995-10-04	METHOD FOR THE PRODUCTION OF REINFORCED ANTI-INTELLECTORY BACTERIA AND VACCINES CONTAINED THEREFORE

Country Status (16)

Country	Link
EP (1)	EP0804542A4 (en)
JP (1)	JP3394047B2 (en)
CN (1)	CN1168693A (en)
AU (1)	AU704283B2 (en)
BR (1)	BR9509276A (en)
CA (1)	CA2202027A1 (en)
CZ (1)	CZ104397A3 (en)
FI (1)	FI971403L (en)
HU (1)	HUT77876A (en)
IL (1)	IL115521A0 (en)
MX (1)	MX9702431A (en)
NO (1)	NO971519L (en)
NZ (1)	NZ295907A (en)
PL (1)	PL182700B1 (en)
SG (2)	SG73510A1 (en)
WO (1)	WO1996011258A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0792347B1 (en) *	1994-10-05	2005-11-23	Antex Biologics, Inc.	Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same
EP2327720A1 (en) *	2003-05-30	2011-06-01	Intercell AG	Enterococcus antigens
US20100074846A1 (en) *	2006-03-17	2010-03-25	Ellis John A	Campylobacter Vaccines and Methods of use
EP2161035B1 (en) *	2007-05-28	2019-08-21	Daiichi Sankyo Company, Limited	Bordetella parapertussis-containing whole-cell vaccine composition
CN107513553B (en) *	2017-09-18	2021-05-18	江南大学	Method for screening lactobacillus with antagonistic campylobacter jejuni infection function
CN109633151B (en) *	2018-12-26	2022-03-11	西北农林科技大学	A kind of Salmonella Enteritidis detection method, test strip and application
WO2020141103A1 (en)	2018-12-31	2020-07-09	Bellevacc As	Bacterial vaccine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0533492A2 (en) *	1991-09-18	1993-03-24	Amgen Inc.	A hepatitis B vaccine formulation incorporating a bile acid salt

1995
- 1995-10-04 EP EP95937449A patent/EP0804542A4/en not_active Withdrawn
- 1995-10-04 HU HU9702303A patent/HUT77876A/en unknown
- 1995-10-04 SG SG1998000819A patent/SG73510A1/en unknown
- 1995-10-04 NZ NZ295907A patent/NZ295907A/en unknown
- 1995-10-04 CA CA002202027A patent/CA2202027A1/en not_active Abandoned
- 1995-10-04 AU AU39561/95A patent/AU704283B2/en not_active Ceased
- 1995-10-04 FI FI971403A patent/FI971403L/en not_active IP Right Cessation
- 1995-10-04 CZ CZ971043A patent/CZ104397A3/en unknown
- 1995-10-04 PL PL95319580A patent/PL182700B1/en not_active IP Right Cessation
- 1995-10-04 CN CN95196589A patent/CN1168693A/en active Pending
- 1995-10-04 JP JP51271696A patent/JP3394047B2/en not_active Expired - Fee Related
- 1995-10-04 SG SG1998000815A patent/SG73509A1/en unknown
- 1995-10-04 WO PCT/US1995/013196 patent/WO1996011258A1/en not_active Ceased
- 1995-10-04 MX MX9702431A patent/MX9702431A/en not_active IP Right Cessation
- 1995-10-04 BR BR9509276A patent/BR9509276A/en not_active Application Discontinuation
- 1995-10-05 IL IL11552195A patent/IL115521A0/en unknown
1997
- 1997-04-03 NO NO971519A patent/NO971519L/en not_active Application Discontinuation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0533492A2 (en) *	1991-09-18	1993-03-24	Amgen Inc.	A hepatitis B vaccine formulation incorporating a bile acid salt

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
95TH GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, D.C., USA, MAY 21-25, 1995. ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY 95 (0). 1995. 183 *
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; ROLLINS D M ET AL: "Functional In Vitro Assays for Maximizing Campylobacter Cross-Strain Agglutination Through Optimization of Culture Conditions.", XP002075401 *
POPE L M ET AL: "Increased protein secretion and adherence to HeLa cells by Shigella spp. following growth in the presence of bile salts.", INFECTION AND IMMUNITY, (1995 SEP) 63 (9) 3642-8, XP002075400 *
See also references of WO9611258A1 *

Also Published As

Publication number	Publication date
CZ104397A3 (en)	1998-06-17
NO971519D0 (en)	1997-04-03
CA2202027A1 (en)	1996-04-18
PL182700B1 (en)	2002-02-28
EP0804542A1 (en)	1997-11-05
SG73510A1 (en)	2000-06-20
AU3956195A (en)	1996-05-02
WO1996011258A1 (en)	1996-04-18
JPH10507347A (en)	1998-07-21
FI971403A0 (en)	1997-04-04
FI971403A7 (en)	1997-06-04
JP3394047B2 (en)	2003-04-07
HUT77876A (en)	1998-09-28
AU704283B2 (en)	1999-04-15
SG73509A1 (en)	2000-06-20
NZ295907A (en)	1999-04-29
PL319580A1 (en)	1997-08-18
CN1168693A (en)	1997-12-24
BR9509276A (en)	1997-11-18
IL115521A0 (en)	1996-06-18
NO971519L (en)	1997-05-27
FI971403L (en)	1997-06-04
MX9702431A (en)	1998-05-31

Legal Events

Date	Code	Title	Description
1997-09-19	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1997-11-05	17P	Request for examination filed	Effective date: 19970417
1997-11-05	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-11-05	AX	Request for extension of the european patent	Free format text: SI PAYMENT 970417
1998-10-28	A4	Supplementary search report drawn up and despatched	Effective date: 19980914
1998-10-28	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
2002-01-30	17Q	First examination report despatched	Effective date: 20011212
2004-05-28	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-07-14	18D	Application deemed to be withdrawn	Effective date: 20040101

Publication	Publication Date	Title
DE69403797D1 (en)	1997-07-17	NON-WOVEN MATERIALS AND METHOD FOR PRODUCING THE SAME
DE69322094D1 (en)	1998-12-17	HETEROGENEOUS MEMBRANE AND METHOD FOR THE PRODUCTION THEREOF
EP0783727A4 (en)	1998-01-14	MICROSTRUCTURES AND METHOD FOR PRODUCING MICROSTRUCTURES
DE59810636D1 (en)	2004-02-26	METHOD FOR PRODUCING GLUFOSINATES AND INTERMEDIATE PRODUCTS THEREFOR
DE69535674D1 (en)	2008-02-07	PROCESS FOR PREPARING L-VALIN AND L-LEUCINE
EP0655777A3 (en)	1997-01-08	Varactor and method of manufacture.
DE69300528D1 (en)	1995-11-02	Micropump and manufacturing method.
DE59702349D1 (en)	2001-10-31	METHOD FOR PRODUCING AMINES AND AMINONITRILES
DE69511248D1 (en)	1999-09-09	POLYCARBOMATES, METHOD FOR PRODUCING POLYCARBOMATS AND METHOD FOR PRODUCING POLYISOCYANATES
DE59504187D1 (en)	1998-12-17	Process for the preparation of ultra-pure bisphenol-A and its use
DE69425748D1 (en)	2000-10-05	TRANSISTORS AND METHOD FOR THE PRODUCTION
DE69531196D1 (en)	2003-08-07	DEVICE AND METHOD FOR THE PRODUCTION OF TRANSMISSIONS SHOLOGRAMS
DE59703443D1 (en)	2001-05-31	METHOD FOR PRODUCING AMINES AND AMINONITRILES
DE59002992D1 (en)	1993-11-11	Hotel can and method of making the same.
DE69613964D1 (en)	2001-08-23	METHOD FOR PRODUCING PENTAFLUOROETHANE AND TETRAFLUOROCHLOROETHANE
DE69321848D1 (en)	1998-12-03	METHOD FOR PRODUCING 1,1,1,2,3,3-HEXAFLUORPROPANE AND TETRAFLUORCHLOROPROPEN
DE59606485D1 (en)	2001-04-05	Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
EP0804542A4 (en)	1998-10-28	METHOD FOR THE PRODUCTION OF REINFORCED ANTI-INTELLECTORY BACTERIA AND VACCINES CONTAINED THEREFORE
DE69902714D1 (en)	2002-10-10	Process for the production of natural rubber and natural rubber obtained therewith
DE59606489D1 (en)	2001-04-05	Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
DE59101473D1 (en)	1994-06-01	Process for the preparation of N-aryl-substituted 2-aminoalkyl-2-hydroxy-alkylamines and N-aryl-substituted piperazines.
DE69313297D1 (en)	1997-09-25	BENZOFURANONE, BENZODIFURANTRIONS AND METHOD FOR THE PRODUCTION OF BENZODIFURANDIONS
DE59106553D1 (en)	1995-10-26	METHOD FOR PRODUCING CHLORINE FLUORNITROBENZENE AND DIFLUORNITROBENZENE.
ATE370751T1 (en)	2007-09-15	METHOD FOR PRODUCING DECONTAMINATED AND STERILIZED CORKS
EP0726715A4 (en)	1997-02-26	PSYLLIUM CONTAINER STICK-FORMED CONFECT; METHOD FOR PRODUCING THE SAME AND USE THEREOF